Search Within

Rachel Nicole Grisham

Formats
  1. Journal Article (80)
  2. Meeting Abstract (78)
  3. Review (9)
  4. Guidelines (3)
  5. Book Section (2)
  6. Editorial (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (175)
  2. GDMT, Medicine (175)
  3. Gynecologic Medicine Service (175)
  4. Gynecology Disease Management Team (175)
  5. Solid Tumor Oncology Division (175)
  6. Surgery (76)

More Groups

People
  1. Carol Aghajanian (87)
  2. Roisin O'Cearbhaill (68)
  3. Alexia Iasonos (63)
  4. Qin Zhou (56)
  5. Dennis Chi (52)
  6. Kara Long Roche (49)

More People

Years
  1. 2025 (13)
  2. 2024 (29)
  3. 2023 (26)
  4. 2022 (23)
  5. 2021 (12)
  6. 2020 (21)

More Years

Publications
  1. Gynecologic Oncology (49)
  2. Journal of Clinical Oncology (37)
  3. International Journal of Gynecological Cancer (28)
  4. Clinical Cancer Research (8)
  5. Cancer (7)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (50)
  2. American Society of Clinical Oncology (42)
  3. Lippincott Williams & Wilkins (30)
  4. American Association for Cancer Research (10)
  5. Wiley Blackwell (8)
  6. Nature Publishing Group (6)

More Publishers

Results (175)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management of patients with early-stage ovarian clear cell carcinoma: Risk stratification and fertility conservation
    Journal Article

    Manning-Geist, B.; Gordhandas, S.; Hodgson, A.; Zhou, Q. C.; Iasonos, A.; Chi, D. S.; Ellenson, L.; Aghajanian, C. A.; Abu-Rustum, N. R.; Leitao, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of VS-6766 (RAF/MEK clamp) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Banerjee, S. N.; Monk, B. J.; Van Nieuwenhuysen, E.; Moore, K. N.; Oaknin, A.; Fabbro, M.; Colombo, N.; O'Malley, D. M.; Coleman, R. L.; Oza, A. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Advancements in low-grade serous carcinoma of the ovary and peritoneum
    Review

    Grisham, R. N.; Chui, M. H.
    Current Oncology Reports (2022)

    Fulltext@MSK | Save
  • MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma
    Journal Article

    Manning-Geist, B.; Gordhandas, S.; Liu, Y. L.; Zhou, Q.; Iasonos, A.; Da Cruz Paula, A.; Mandelker, D.; Long Roche, K.; Zivanovic, O.; Maio, A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Ovarian cancer, version 3.2022: Featured updates to the NCCN Guidelines
    Journal Article

    Armstrong, D. K.; Alvarez, R. D.; Backes, F. J.; Bakkum-Gamez, J. N.; Barroilhet, L.; Behbakht, K.; Berchuck, A.; Chen, L. M.; Chitiyo, V. C.; Cristea, M.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: A review and clinical guide for hereditary predisposition genes
    Review

    Liu, Y. L.; Breen, K.; Catchings, A.; Ranganathan, M.; Latham, A.; Goldfrank, D. J.; Grisham, R. N.; Long Roche, K.; Frey, M. K.; Chi, D. S.; more...
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer
    Journal Article

    Manning-Geist, B. L.; Gordhandas, S. B.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Lichtman, S. M.; Sabbatini, P. J.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save